FHA
HELP

Flagship Harbor Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Flagship Harbor Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-105
Closed -$859 – 1040
2025
Q4 		$859 Buy
+105
New +$676 ﹤0.01% 1958
2023
Q4 		– Sell
-303
Closed -$6.11K – 632
2023
Q3 		$6.11K Buy
+303
New +$4.46K ﹤0.01% 605

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Flagship Harbor Advisors's HELP Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2026, closing a stake of 105 shares — an estimated $859 sold.

Flagship Harbor Advisors first reported a position in HELP in Q3 2023 and held it in 2 quarters. The position peaked at $6.11K in Q3 2023. 81 funds tracked by Wall St. Rank hold HELP as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 105 Helus Pharma Inc. Common Stock shares in Q1 2026, an estimated $859.
  • Flagship Harbor Advisors first reported a position in Helus Pharma Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Flagship Harbor Advisors's Helus Pharma Inc. Common Stock position peaked at $6.11K in Q3 2023.
  • 81 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.